A significant (*p < 0.05) fold-change was found for specific targets in brains related to glucose metabolism, SLC2A1, BDNF, MTOR and VEGFα within FCDIIa/b vs other FCD subtypes (Fig. 1a). This evidence concerns the gene VEGFA and fleck corneal dystrophy.